BIB icon

ProShares Ultra NASDAQ Biotechnology

38 hedge funds and large institutions have $23.3M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding:

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

50% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 10

62% less call options, than puts

Call options by funds: $8.07M | Put options by funds: $21.4M

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.07M
Puts
$21.4M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.37M
2
$3.29M
3
$2.65M
4
$1.73M
5
$1.6M
6
$1.4M
7
$1.19M
8
$1.16M
9
$858K
10
$761K
11
$612K
12
$572K
13
$514K
14
$258K
15
$233K
16
$232K
17
$224K
18
$170K
19
$99K
20
$83K
21
$58K
22
$57K
23
$45K
24
$26K
25
$23K